NovaBay Pharmaceuticals, Inc. (NBY)

USD 0.54

(5.26%)

Inventory Summary of NovaBay Pharmaceuticals, Inc.

  • NovaBay Pharmaceuticals, Inc.'s latest annual inventory in 2023 was 2.87 Million USD , down -16.29% from previous year.
  • NovaBay Pharmaceuticals, Inc.'s latest quarterly inventory in 2024 Q2 was 700 Thousand USD , up 5.58% from previous quarter.
  • NovaBay Pharmaceuticals, Inc. reported annual inventory of 3.43 Million USD in 2022, up 6.74% from previous year.
  • NovaBay Pharmaceuticals, Inc. reported annual inventory of 3.22 Million USD in 2021, up 429.61% from previous year.
  • NovaBay Pharmaceuticals, Inc. reported quarterly inventory of 663 Thousand USD for 2024 Q1, down -76.96% from previous quarter.
  • NovaBay Pharmaceuticals, Inc. reported quarterly inventory of 3.79 Million USD for 2023 Q1, up 10.47% from previous quarter.

Annual Inventory Chart of NovaBay Pharmaceuticals, Inc. (2023 - 2003)

Historical Annual Inventory of NovaBay Pharmaceuticals, Inc. (2023 - 2003)

Year Inventory Inventory Growth
2023 2.87 Million USD -16.29%
2022 3.43 Million USD 6.74%
2021 3.22 Million USD 429.61%
2020 608 Thousand USD 23.58%
2019 492 Thousand USD 75.71%
2018 280 Thousand USD -44.44%
2017 504 Thousand USD -42.27%
2016 873 Thousand USD -35.09%
2015 1.34 Million USD 158.16%
2014 521 Thousand USD 125.54%
2013 231 Thousand USD 904.35%
2012 23 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2003 - USD 0.0%

Peer Inventory Comparison of NovaBay Pharmaceuticals, Inc.

Name Inventory Inventory Difference
AIM ImmunoTech Inc. -1.18 Million USD 342.99%
Ampio Pharmaceuticals, Inc. 1.00 USD -287699900.0%
Armata Pharmaceuticals, Inc. - USD -Infinity%
Actinium Pharmaceuticals, Inc. - USD -Infinity%
Azitra, Inc. -215.21 Thousand USD 1436.778%
Can-Fite BioPharma Ltd. - USD -Infinity%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. - USD -Infinity%
CEL-SCI Corporation 2.24 Million USD -27.976%
iBio, Inc. - USD -Infinity%
Lineage Cell Therapeutics, Inc. - USD -Infinity%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. - USD -Infinity%
Navidea Biopharmaceuticals, Inc. 427.34 Thousand USD -573.228%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. - USD -Infinity%
BiomX Inc. - USD -Infinity%
BiomX Inc. - USD -Infinity%
Protalix BioTherapeutics, Inc. 19.04 Million USD 84.894%
Palatin Technologies, Inc. - USD -Infinity%
Scorpius Holdings, Inc. 909.15 Thousand USD -216.447%
Theriva Biologics, Inc. - USD -Infinity%